FDA Approved: QULIPTA — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for QULIPTA (atogepant) from AbbVie Inc., expanding the product's approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)

Snippet

SUPPL AP for QULIPTA (ATOGEPANT)